Strongin A Y, Marmer B L, Grant G A, Goldberg G I
Division of Dermatology, Washington University School of Medicine, St. Louis, Missouri 63110-1093.
J Biol Chem. 1993 Jul 5;268(19):14033-9.
Human 72-kDa type IV collagenase (72T4Cl) is secreted as a proenzyme that can form a specific stoichiometric complex with the tissue inhibitor of metalloproteases TIMP-2 via interaction with the carboxyl-terminal domain of the enzyme. Both complexed and free enzymes can be activated by treatment with organomercurials. The mechanism of the 72T4Cl activation under physiological conditions is not known. Here we describe a "plasma membrane-dependent" activation of inhibitor-free 72T4Cl and identify the first conversion intermediate as a 64-kDa species resulting from cleavage of the Asn37-Leu peptide bond in the presence of plasma membranes from 12-O-tetradecanoylphorbol-13-acetate-induced HT1080 cells. This reaction is specific for 72T4Cl in that a closely related proenzyme (92-kDa type IV collagenase) is resistant to activation under the same conditions. Formation of the 72T4Cl.TIMP-2 complex inhibits activation at the level of the initial Asn37-Leu cleavage. Addition of TIMP-1 has no effect on this reaction, but blocks the autocatalytic conversion of the Leu38 intermediate into a 62-kDa active enzyme with an amino-terminal Tyr81. Membrane-dependent activation of 72T4Cl is competitively inhibited in the presence of a 26-kDa peptide derived from the carboxyl-terminal domain of the enzyme. The results suggest that interaction of the carboxyl-terminal domain of the enzyme with a membrane-associated component(s) causes initiation of enzyme activation through an autoproteolytic mechanism.
人72-kDa IV型胶原酶(72T4Cl)以酶原形式分泌,通过与该酶的羧基末端结构域相互作用,它可与金属蛋白酶组织抑制剂TIMP-2形成特定的化学计量复合物。复合酶和游离酶均可通过有机汞处理而被激活。72T4Cl在生理条件下的激活机制尚不清楚。在此,我们描述了无抑制剂的72T4Cl的“质膜依赖性”激活,并鉴定出第一个转化中间体是一种64-kDa的物种,它是在来自12-O-十四烷酰佛波醇-13-乙酸酯诱导的HT1080细胞的质膜存在下,Asn37-Leu肽键断裂产生的。该反应对72T4Cl具有特异性,因为一种密切相关的酶原(92-kDa IV型胶原酶)在相同条件下对激活具有抗性。72T4Cl.TIMP-2复合物的形成在初始Asn37-Leu裂解水平上抑制激活。添加TIMP-1对该反应无影响,但可阻断Leu38中间体自催化转化为具有氨基末端Tyr81的62-kDa活性酶。在存在源自该酶羧基末端结构域的26-kDa肽的情况下,72T4Cl的膜依赖性激活受到竞争性抑制。结果表明,该酶的羧基末端结构域与膜相关成分的相互作用通过自蛋白水解机制引发酶的激活。